GeNeuro SA (GNRO.PA) Stock Price

€0.036 0%

Sign up
to add to portfolio

AI Score

Sell

  • Alternative

    4

  • Fundamental

    1

  • Technical

    3

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on GeNeuro SA, AI stock picks, stock alerts and much more.

Sign up

GNRO.PA AI Stock Analysis

AI stock analysis for GNRO.PA is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like GeNeuro SA (GNRO.PA) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

GeNeuro SA (GNRO.PA) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of GeNeuro SA (GNRO.PA), currently trading at €0.036, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About GNRO.PA

LSE

  • GeNeuro SA, a clinical-stage biopharmaceutical company, develops drugs for the treatment of neurodegenerative and autoimmune diseases.

  • Symbol

    GNRO.PA

  • Market

    EURONEXT

  • Industry

    Biotechnology

  • Market Cap

    1.1M

Similar Stocks

VLA.PA Valneva SE
VLA.PA		 €5.05
2.4%
5
TUB.BR Financière de Tubize SA
TUB.BR		 €160.6
0.4%
8
OSE.PA OSE Immunotherapeutics SA
OSE.PA		 €6.32
0.5%
6
UCB.BR UCB SA
UCB.BR		 €197.3
0.9%
6
IPH.PA Innate Pharma S.A.
IPH.PA		 €2.01
1.9%
5

News

GeNeuro SA: End of the Liquidity Contract With GILBERT DUPONT

GeNeuro SA: End of the Liquidity Contract With GILBERT DUPONT
July 10, 2024. Investing.com

GNRO.PA Alternative Data

Web Traffic

GeNeuro SA receives an estimated 0 monthly visitors to geneuro.com.

  • Web Traffic

    0

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

Twitter Followers

GeNeuro SA has 542 Twitter Followers on its main Twitter (also known as X) account.

  • Twitter Followers

    542

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    1.3%

  • YoY Change

    1.3%

Youtube Subscribers

GeNeuro SA has 205 subscribers on its main Youtube channel.

  • Youtube Subscribers

    205

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0.5%

  • YoY Change

    0.5%

Job Postings

GeNeuro SA currenly has an estimated 0 open job postings.

  • Job Postings

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

LinkedIn Employees

According to LinkedIn, GeNeuro SA has 16 employees.

  • LinkedIn Employees

    16

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

News Mentions

GeNeuro SA was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

Reddit Mentions

GeNeuro SA has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • 1 Month Change

    0%

  • 3 Month Change

    0%

GNRO.PA Financials

GNRO.PA Key Metrics

  • Total Revenue

    €0

  • Net Income

    -€7.9M

  • Earnings per Share

    -€0.32

  • Free cash flow

    -€5.4M

  • EBITDA

    -€7.4M

  • EBITDA Ratio

    0

  • Total Assets

    €6.3M

GNRO.PA 2-year Revenue & Income
GNRO.PA 2-year Free Cash Flow

GNRO.PA Technicals

GNRO.PA SMA
GNRO.PA RSI

FAQ

What's the current price of GeNeuro SA (GNRO.PA) Stock?
The price of an GeNeuro SA (GNRO.PA) share is €0.036.

What's the market cap of GeNeuro SA?
The current market cap of GeNeuro SA is 1.1M.

Should I buy or sell GNRO.PA?
GeNeuro SA exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.

Is GeNeuro SA a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in GeNeuro SA stock. There are several bearish signals and market challenges that could negatively impact GeNeuro SA's future performance, suggesting that caution should be exercised before making any investment decisions.

Is now a good time to buy GeNeuro SA (GNRO.PA) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy GeNeuro SA stock right now, as the outlook appears bearish.

What are some stocks similar to GeNeuro SA (GNRO.PA) that investors often compare it to?
GeNeuro SA (GNRO.PA) is often compared to similar stocks such as Valneva SE, Financière de Tubize SA, OSE Immunotherapeutics SA, UCB SA and Innate Pharma S.A..

What is the forecast for GeNeuro SA's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast GeNeuro SA's stock price to be around €0.036 in 2026. Starting from the current price of €0.036, this represents a 0% change in price, indicating a neutral outlook for the stock.

How to buy GeNeuro SA (GNRO.PA) Stock?
GeNeuro SA stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy GeNeuro SA shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.